GST Council set to ease tax burden on clinical trials, highway concessions

The GST Council is expected to revisit the tax treatment of clinical trials conducted domestically for overseas sponsors, potentially classifying them as exports to provide relief to Indian research institutions and contract research organizations. The change would align the sector with international practices and make India a more competitive destination for multinational pharmaceutical companies seeking trial sites.

Beyond clinical trials, the Council's agenda includes examining the GST framework for highway concessions and toll operations, with officials indicating a need to streamline the current structure. The review comes as the sector seeks greater clarity on input tax credit mechanisms that have complicated operations for highway operators.

E-commerce logistics also features prominently in the Council's deliberations. The tax authority is assessing whether adjustments to the GST treatment of delivery services can address operational challenges facing the burgeoning online retail sector, particularly regarding inter-state deliveries and warehouse operations.

A fourth item under consideration involves services rendered between foreign shipping lines and their Indian liaison offices. Officials are examining whether the current GST classification adequately captures the nature of these inter-office transactions, with potential implications for India's maritime trade facilitation efforts.

The GST Council, comprising representatives from the central government and all states, is expected to finalize its recommendations at an upcoming meeting, though no specific timeline has been announced for implementation of any approved changes.